Skip to main content
SpringerLink
Log in

Rheumatologische Erkrankungen in der Schwangerschaft

Rheumatic diseases during pregnancy

  • Leitthema
  • Published:
Der Gynäkologe Aims and scope

An Erratum to this article was published on 03 May 2016

Zusammenfassung

Rheumatische Erkrankungen in der Schwangerschaft haben Einfluss auf maternale sowie fetale Morbidität und Mortalität. Umgekehrt kann eine Schwangerschaft die rheumatische Erkrankung beeinflussen: Während sich die rheumatoide Arthritis während der Schwangerschaft häufig bessert, müssen Frauen mit Lupus erythematodes oder ankylosierender Spondylitis mit vermehrten Schüben ihrer Grunderkrankung rechnen. Die präkonzeptionelle interdisziplinäre Beratung der Frauen ist entscheidend. Eine individuelle, interdisziplinäre Therapie der Frau, die die Auswirkungen auf Fetus und Kind beachtet, sollte an einem Perinatalzentrum Level I erfolgen.

Abstract

Rheumatic diseases have an impact on maternal and fetal morbidity and mortality. Vice versa a pregnancy can influence the rheumatic disease: while rheumatoid arthritis can often improve during pregnancy, patients with systemic lupus erythematosus or ankylosing spondylitis can develop an increased incidence of flares of the underlying disease. The preconception interdisciplinary consultation of women is decisive. In the setting of individual interdisciplinary management of risk patients in specialized centers, morbidity and mortality during pregnancy can be reduced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wallenius M, Skomsvoll JF, Irgens LM et al (2010) Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis 69:332–336

    Article  CAS  PubMed  Google Scholar 

  2. Jahaweer D, Zhu JL, Nohr EA, Olsen J (2011) Time to pregnancy among woman with rheumatoid arthritis. Arthritis Rheum 63:1517–1521

    Article  Google Scholar 

  3. Man YA de, Dolhain RJ, Geijn FE van de et al (2009) Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 60:3196–3206

    Article  PubMed  Google Scholar 

  4. Chakravarty EF, Nelson L, Krishnan E (2006) Obstetric hospitalizations in the United States for woman with systemic lupus erythematodes and rheumatoid arthritis. Arthritis Rheum 54(3):899–907

    Article  PubMed  Google Scholar 

  5. Fischer-Betz R (2012) Rheumatische Erkrankungen in der Schwangerschaft. Internist 53:1047–1053

    Article  CAS  PubMed  Google Scholar 

  6. Ostensen M, Ostensen H (1998) Ankylosing spondylitis – the female aspect. J Rheumatol 25:120–124

    CAS  PubMed  Google Scholar 

  7. Lui NL, Haroon N, Carty A et al (2011) Effect of pregnancy on ankylosing spondylitis: a case-control study. J Rheumatol 38:2442–2444

    Article  PubMed  Google Scholar 

  8. Ostensen M, Fuhrer L, Mathieu R et al (2004) A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 63:1212–1217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Clowse ME (2007) Lupus activity in pregnancy. Rheum Dis Clin North Am 33:237–252

    Article  PubMed  PubMed Central  Google Scholar 

  10. Clowse ME, Magder LS, Witter F et al (2005) The impact of increased lupus activity on obstretric outcomes. Arthritis Rheum 52:514–521

    Article  PubMed  Google Scholar 

  11. Clowse ME, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54(11):3640–3647

    Article  PubMed  Google Scholar 

  12. Georgiou PE, Politi EN, Katsimbri P et al (2000) Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 39(9):1014–1019

  13. Petri M, Allbritton J (1993) Fetal outcome of lupus pregnancy: a retrospective case-control study of Hopkins Lupus Cohort. J Rheumatol 20:650–656

    CAS  PubMed  Google Scholar 

  14. Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematodes over a 40-yera period. J Rheumatol 32:1709–1712

    PubMed  Google Scholar 

  15. Clowse ME, Magder LS, Witter F, Petri M (2006) Early risk factors for pregnancy loss in lupus. Obstet Gynecol 107(2 Pt 1):293–299

    Article  PubMed  Google Scholar 

  16. Chakravarty EF, Nelson L, Krishnan E (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192:1897–1904

    Article  PubMed  Google Scholar 

  17. Clowse ME, Jamison M, Myers E et al (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2):127.e1–6

    Article  PubMed  PubMed Central  Google Scholar 

  18. Moroni G, Ponticelli C (2003) The risk of pregnancy in patients with lupus nephritis. J Nephrol 16(2):161–167

    PubMed  Google Scholar 

  19. Qazi UM, Petri M (2006) Autoantibodies, low complement, and obesity predict preeclampsia in SLE: a case-control study. Arthritis Rheum 54(9 Suppl):S264

    Article  Google Scholar 

  20. Smyth A, Oliveira GH, Lahr BD et al (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythemtaodes and lupus nephritis. Clin J Am Soc Nephrol 5:2060–2068

    Article  PubMed  PubMed Central  Google Scholar 

  21. Day CJ, Lipkin GW, Savage CO (2009) Lupus nephritis and pregnancy in the 21st century. Nephrol Dial Transplant 24:344–347

    Article  PubMed  Google Scholar 

  22. Bertsias G, Ioannidis JPA, Boletis J et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:195–205

    Article  CAS  PubMed  Google Scholar 

  23. Mok CC, Tang S, To C, Metri M (2005) Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 52:2774–2782

    Article  PubMed  Google Scholar 

  24. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376:1498–1509

    Article  CAS  PubMed  Google Scholar 

  25. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  26. Ruffatti A, Tonello M, Del Ross T et al (2006) Antibody profile and clinical course in primary antiphospholipid syndrome with pregnany morbidity. Thromb Haemost 96:337–341

    CAS  PubMed  Google Scholar 

  27. Ruffatti A, Tonello M, Cavazzana A et al (2009) Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 123:482–487

    Article  CAS  PubMed  Google Scholar 

  28. Ruffatti A, Tonello M, Visenti MS et al (2011) Risk factors for pregnancy failure in patients with antiphospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 50:1684–1689

  29. Bramham K, Hunt BJ, Germain S et al (2010) Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 19:58–64

    Article  CAS  PubMed  Google Scholar 

  30. Danowski A, Azevedo MN de, Souza Papi JA de, Petri M (2009) Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol 36:1195–1199

    Article  CAS  PubMed  Google Scholar 

  31. Izmirly PM, Rivera TL, Buyon JP (2007) Neonatal lupus syndromes. Rheum Dis Clin North Am 33:267–285

    Article  PubMed  Google Scholar 

  32. Saleeb S, Copel J, Friedman D, Buyon JP (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335–2345

    Article  CAS  PubMed  Google Scholar 

  33. Rein AJ, Mevorach D, Perles Z et al (1999) Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogramm-based study. Circulation 119:1867–1872

    Article  Google Scholar 

  34. Jaeggi ET, Fouron JC, Silverman ED et al (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548

    Article  PubMed  Google Scholar 

  35. Izmirly PM, Saxena A, Kim MY et al (2010) Evaluation of the risk of anti-SSA/Ro-SSB/La-antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69:1827–1830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Izmirly PM, Saxena A, Kim MY et al (2011) Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 124:1927–1935

    Article  PubMed  PubMed Central  Google Scholar 

  37. Fischer-Betz RE, Gromnica-Ihle E (2010) Pregnancy and inflammatory rheumatic diseases. Z Rheumatol 69:633–641

    Article  CAS  PubMed  Google Scholar 

  38. Gerosa M, Meroni PL, Cimaz R (2014) Safety considerations when prescribing immunpsuppression medication to pregnant woman. Expert Opin Drug Saf 5:1–9

    Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. A. von Figura, S. Patschan, N. Bock und G. A. Müller geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Zentrum Innere Medizin, Abteilung Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, 37099, Göttingen, Deutschland

    A. von Figura, S. Patschan &  G.A. Müller

  2. Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen, Göttingen, Deutschland

    N. Bock

Authors
  1. A. von Figura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Patschan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G.A. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G.A. Müller.

Additional information

Ein Erratum zu diesem Beitrag ist unter http://dx.doi.org/10.1007/s00129-016-3876-3 zu finden.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

von Figura, A., Patschan, S., Bock, N. et al. Rheumatologische Erkrankungen in der Schwangerschaft. Gynäkologe 48, 117–123 (2015). https://doi.org/10.1007/s00129-014-3411-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-014-3411-3

Schlüsselwörter

Keywords

Search

Navigation